Phibro Animal Health Corp (PAHC) stock
PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 22/3046% below fair value
$35.57+0.65 (+1.86%)
Close on Nov 18, 2026Market cap $1.44BP/E 14.6Yield 1.35%
Phibro Animal Health operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Phibro Animal Health's operating income for the twelve months ending Jun 30, 2026 was $194.40M, up 76.0% year over year. For fiscal 2026 it was $194.40M, up 76.0% from the year before. Over ten years it grew 8.5% a year on average. The highest annual figure on record is $194.40M in fiscal 2026.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $194.40M | +76.0% |
| FY2025 | Jun 30, 2025 | $110.47M | +107.2% |
| FY2024 | Jun 30, 2024 | $53.32M | -25.8% |
| FY2023 | Jun 30, 2023 | $71.85M | -9.0% |
| FY2022 | Jun 30, 2022 | $78.99M | +5.5% |
| FY2021 | Jun 30, 2021 | $74.87M | +8.2% |
| FY2020 | Jun 30, 2020 | $69.19M | -16.9% |
| FY2019 | Jun 30, 2019 | $83.23M | -15.9% |
| FY2018 | Jun 30, 2018 | $98.93M | +1.0% |
| FY2017 | Jun 30, 2017 | $97.93M | +14.2% |
| FY2016 | Jun 30, 2016 | $85.74M | -2.2% |
| FY2015 | Jun 30, 2015 | $87.67M | +37.4% |
| FY2014 | Jun 30, 2014 | $63.79M | +12.4% |
| FY2013 | Jun 30, 2013 | $56.73M | +15.0% |
| FY2012 | Jun 30, 2012 | $49.33M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $48.16M | +42.8% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $44.65M | +33.2% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $50.33M | +97.1% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $51.26M | +189.6% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $33.72M | +83.1% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $33.52M | +68.2% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $25.53M | +62.6% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $17.70M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $18.42M | -22.5% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $19.92M | +7.4% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $15.70M | -0.9% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$726.00K | -105.3% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $23.77M | +3.8% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $18.55M | -3.3% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $15.84M | -28.9% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $13.68M | -6.4% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $22.89M | +19.5% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $19.19M | -4.7% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $22.29M | +12.1% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $14.61M | -6.9% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $19.16M | +5.7% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $20.13M | -5.6% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $19.89M | +1.4% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $15.69M | +54.6% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $18.12M | +49.8% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $21.32M | -5.5% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $19.61M | -23.7% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $10.15M | -55.6% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $12.10M | -53.7% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $22.57M | -14.8% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $25.71M | +7.4% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $22.85M | +2.1% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $26.11M | +11.0% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $26.49M | -11.6% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $23.94M | +5.8% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $22.39M | +2.6% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $23.52M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $29.97M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $22.63M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $21.81M | – |
See a number that looks wrong?